HUT68533A - Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamides as an active ingredient - Google Patents

Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamides as an active ingredient Download PDF

Info

Publication number
HUT68533A
HUT68533A HU9302821A HU9302821A HUT68533A HU T68533 A HUT68533 A HU T68533A HU 9302821 A HU9302821 A HU 9302821A HU 9302821 A HU9302821 A HU 9302821A HU T68533 A HUT68533 A HU T68533A
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
contain
compositions according
formula
chloro
Prior art date
Application number
HU9302821A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9302821D0 (en
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9302821D0 publication Critical patent/HU9302821D0/hu
Publication of HUT68533A publication Critical patent/HUT68533A/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU9302821A 1992-10-07 1993-10-06 Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamides as an active ingredient HUT68533A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (2)

Publication Number Publication Date
HU9302821D0 HU9302821D0 (en) 1993-12-28
HUT68533A true HUT68533A (en) 1995-04-27

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9302821A HUT68533A (en) 1992-10-07 1993-10-06 Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamides as an active ingredient

Country Status (21)

Country Link
EP (1) EP0662831A1 (pl)
JP (1) JP2721042B2 (pl)
KR (1) KR950703338A (pl)
CN (1) CN1089138A (pl)
AU (1) AU676200B2 (pl)
BR (1) BR9307182A (pl)
CA (1) CA2146448A1 (pl)
CZ (1) CZ282702B6 (pl)
EG (1) EG20289A (pl)
FI (1) FI934387L (pl)
HU (1) HUT68533A (pl)
IL (1) IL107122A (pl)
MX (1) MX9306222A (pl)
MY (1) MY109680A (pl)
NO (1) NO951350L (pl)
NZ (1) NZ256164A (pl)
PL (1) PL174170B1 (pl)
RU (1) RU2119353C1 (pl)
TW (1) TW438798B (pl)
WO (1) WO1994007488A1 (pl)
ZA (1) ZA937405B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
EP0827399A1 (en) * 1995-04-24 1998-03-11 Pfizer Inc. Inhibiting photodecomposition of 3-substituted-2-oxindoles
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (ja) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 カプセル充填用組成物
US20220401380A1 (en) * 2019-10-25 2022-12-22 Cardiol Therapeutics Inc. Cannabidiol compositions for use in treating heart conditions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
UA25898A1 (uk) * 1987-02-02 1999-02-26 Пфайзер Інк. Спосіб одержаhhя кристалічhої hатрієвої солі 5-хлор-3-(2-теhоїл)-2-оксііhдол-1-карбоксаміду
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
WO1991012821A1 (fr) * 1990-03-02 1991-09-05 Shiseido Company, Ltd. Composition d'emulsion aqueuse contenant un analgesique anti-inflammatoire steroidien
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
CA2117351C (en) * 1992-01-13 1998-03-03 Julian Belknap Lo Preparation of tablets of increased strength

Also Published As

Publication number Publication date
RU2119353C1 (ru) 1998-09-27
FI934387A0 (fi) 1993-10-06
JP2721042B2 (ja) 1998-03-04
NO951350L (no) 1995-06-06
TW438798B (en) 2001-06-07
CA2146448A1 (en) 1994-04-14
BR9307182A (pt) 1999-03-30
JPH07507809A (ja) 1995-08-31
FI934387A7 (fi) 1994-04-08
IL107122A0 (en) 1993-12-28
ZA937405B (en) 1995-04-06
MX9306222A (es) 1994-04-29
FI934387L (fi) 1994-04-08
CZ282702B6 (cs) 1997-09-17
HU9302821D0 (en) 1993-12-28
NZ256164A (en) 1997-03-24
AU676200B2 (en) 1997-03-06
KR950703338A (ko) 1995-09-20
MY109680A (en) 1997-04-30
EG20289A (en) 1998-07-30
WO1994007488A1 (en) 1994-04-14
AU4839293A (en) 1994-04-26
PL174170B1 (pl) 1998-06-30
NO951350D0 (no) 1995-04-06
IL107122A (en) 1998-08-16
CZ87895A3 (en) 1995-10-18
PL308307A1 (en) 1995-07-24
CN1089138A (zh) 1994-07-13
EP0662831A1 (en) 1995-07-19

Similar Documents

Publication Publication Date Title
EP0948332B1 (en) Antiherpetic medicated stick containing acyclovir for topical application
CA1140853A (en) Cerebral therapeutic agent and its use
JP4209467B2 (ja) 経口投与用製剤組成物
KR19990067603A (ko) 9-하이드록시리스페리돈 지방산 에스테르의 수성 현탁액
JP2852043B2 (ja) 安定化薬剤組成物
EP0357030B1 (en) Use of thromboxane A2 receptor antagonists for the preparation of a pharmaceutical composition for treating skin injuries
HK1015691A1 (en) Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia
HK26294A (en) Stabilization of the preservative thiomersal in ophthalmic pharmaceutical compositions
JPH09504279A (ja) 新エマルジョン製剤
KR20000048812A (ko) 병원성 유기체에 의한 비인두 전이증식 관련 세균 감염 치료용약제를 제조하기 위한 뮤피로신의 용도
JP2006503026A (ja) 局所施用のためのフェニルピリドン化合物の安定なクリーム製剤
HUT68533A (en) Pharmaceutical compositions containing 3-substituted-2-oxindole-1-carboxamides as an active ingredient
US5795902A (en) 3-substituted 2-oxindole-1 carboxamide pharmaceutical compositions
JPH025732B2 (pl)
JP3506474B2 (ja) 安定性の向上した乾癬治療剤
KR100475388B1 (ko) 1,2,4-벤조트리아진옥사이드의경구겔캡슐제제
US6071974A (en) Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation
US4612310A (en) Antirheumatically active suppositories
JP2002541087A (ja) 防腐添加剤を含有するプロポフォール組成物
US7888392B2 (en) Ointment
EP0339176A1 (en) Suppository containing a non-steroidal anti-inflammatory medicament
WO1999051219A1 (en) Pleuromutilin derivatives for treating nasopharynx infection
JPH0276816A (ja) 外用剤
JPH0368009B2 (pl)
SK847488A3 (en) Process for producing of cyclosporine a

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee